A detailed history of Reyes Financial Architecture, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Reyes Financial Architecture, Inc. holds 31 shares of LLY stock, worth $26,573. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31
Holding current value
$26,573
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $22,543 - $28,893
31 New
31 $23.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $814B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Reyes Financial Architecture, Inc. Portfolio

Follow Reyes Financial Architecture, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reyes Financial Architecture, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Reyes Financial Architecture, Inc. with notifications on news.